Oruka Therapeutics, Inc.
corporate_fare Company Profile
Oruka Therapeutics, Inc. (NASDAQ:ORKA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for ORKA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Oruka Therapeutics' Q4 Loss Narrows Beyond Expectations, Shares Hit 52-Week High
- Oruka Therapeutics Reports Strong Clinical Progress for Lead Programs & Secures Over $200M in New Capital
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$105.43M
Op. Cash Flow
-$88.21M
Free Cash Flow
-$88.42M
Operating Income
-$122.05M
Cash & Equivalents
$46.94M
Debt / Equity
0.00×
Shares Outstanding
48.72M sh
Source: 10-K · filed 2026-03-12 · accession 0001213900-26-026929
show_chartPrice Chart
Loading chart...